基于跨理论改变模型的家庭访视对出院的非酒精性脂肪性肝病患者生活方式干预的依从性调查

doi:10.3969/j.issn.1672-5069.2018.03.040

Abstract

He Xiaoping, Ran Dongmei, Qing Ling. Improved compliance of life style in patients with nonalcoholic fatty liver disease by family visit based on cross-theretical model of change[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 465-466.

References

[1] 孙婉璐,曹海霞,范建高,等. NAFLD的诊断与治疗.中华肝脏病杂志,2014,22(9):705-707.
[2] 范建高,施军平. 2011年NAFLD流行病学与无创诊断研究进展.实用肝脏病杂志,2012,15(2):81-83.
[3] 陈长喜,杜娟,徐益敏,等. 中老年人非酒精性脂肪肝与糖化血红蛋白关系的流行病学研究.中华内科杂志,2015,54(6):517-520.
[4] Younossi ZM,Koenig AB,Abdelatif D,et al.Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence,incidence,and outcomes. Hepatology,2016,64(1):73.
[5] Kleindienst A,Battault S,Belaidi E,et al.Exercise does not activate the β3 adrenergic receptor-eNOS pathway,but reduces inducible NOS expression to protect the heart of obese diabetic mice. Basic Res Cardiol NLM,2016,111(4):1-12.
[6] Sitanggang EJ,Antarianto RD,Swa J,et al.Bone marrow stem cells anti-liver fibrosis potency:inhibition of hepatic stellate cells activity and extracellular matrix deposition. Int J Stem Cells,2017,10(1):69.
[7] Ragab S M M,Elghaffar S K A,El-Metwally T H,et al. Effect of a high fat,high sucrose diet on the promotion of non-alcoholic fatty liver disease in male rats:the ameliorative role of three natural compounds. Lipids Health Dis,2015,14(1):83.
[8] Inoue A,Obayashi K,Sonoda Y,et al.Regulation of matrix metalloproteinase-1 and alpha-smooth muscle actin expression by interleukin-1 alpha and tumour necrosis factor alpha in hepatic stellate cells. Cytotechnology,2016,69(3):461-468.
[9] Djordjevic DB,Zdravkovic M,Nagorni A,et al.A critical approach of guideline therapeutic recommendations for NAFLD.Curr Vasc Pharmacol,2017,20(6):1130-1136.
[10] World Gastroenterology Organisation.World Gastroenterology Organisation Global Guidelines:Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.J Clin Gastroenterol,2014,48(6):467-473.
[11] Shouhed D,Steggerda J,Burch M,et al.The role of bariatric surgery in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.Expert Rev Gastroenterol Hepatol,2017,11(9):797-811.
[12] Rana H,Yadav SS,Reddy HD,et al.Comparative effect of insulin sensitizers and statin on metabolic profile and ultrasonographical score in non alcoholic fatty liver disease. J Clin Diagn Res,2016,10(8):19-23.

[1]	Ren Yufei, Chen Xiaoqing, Kong Weizong, et al.. Effect of salvianolic acid B on autophagy in nonalcoholic fatty liver disease cell model in vitro [J]. Journal of Practical Hepatology, 2019, 22(6): 804-807.
[2]	Li Yingyi, Guo Cuifen, Zhang Ruinan, et al.. Correlation of polymorphism of ALDH2 rs671 to morbidity in individuals prone to nonalcoholic fatty liver disease [J]. Journal of Practical Hepatology, 2019, 22(6): 848-851.
[3]	Zhang Lanhua, Shao Qin, Xia Zhenjuan. Changes of serum 25-(OH) D3 and IL-17 levels are associated with progress of nonalcoholic fatty liver disease in obese children [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 522-525.
[4]	Huo Huiqin, Gong Xiaohong, Li Zhenghong. Assessment of right atrial and ventricular functions in patients with nonalcoholic fatty liver disease-induced liver cirrhosis by real-time three-dimensional echocardiography and speckle tracking imaging [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 244-247.
[5]	Xie Xiao, Lu Lungen. Noninvasive diagnosis and assessment of patients with nonalcoholic steatohepatitis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 301-306.
[6]	Zhong Yan, Su Shuting, Mi Yuqiang.. Treatment of patients with nonalcoholic fatty liver disease [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 145-148.
[7]	Huang Jiaofeng, Lin Su, Wang Mingfang, et al.. Impact of entecavir therapy on hepatic steatosis in patients with chronic hepatitis B and nonalcoholic fatty liver disease [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 863-867.
[8]	Huang Faguang, Li Xiaocheng, Gong Jianping, et al.. Research on insulin resistance related protein molecules in human liver tissues by comprehensive gene expression profiling analysis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 872-876.
[9]	Pu Yonglan, Chen Yuanwen, Fan Jiangao.. Gluten intestinal disease and nonalcoholic fatty liver: One case report [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 981-982.
[10]	Yan Chenli, Wang Jingjing, Wang Jun.. Severity of coronary artery lesions and risk factors in patients with nonalcoholic fatty liver disease complicated by coronary heart disease [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 737-740.
[11]	Bing Hao, Li Yiling.. Correlation between non-alcoholic fatty liver disease and hepatocellular carcinoma:Fact or fiction [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 821-824.
[12]	Yu Aidong, Wang Chuanjie, Li Jianfang. Application of group management by WeChat in improving compliance of patients with chronic hepatitis B receiving nucleos(t)des [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(4): 621-622.
[13]	Wang Xinwei, Lyu Ke, Sun Xiao, et al. Effect of selective β3-adrenergic receptor agonist on hepatic oxidative stress and liver fibrosis in rats with nonalcoholic fatty liver disease [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 384-387.
[14]	Li Caihong, Lian Lingling, Lu Derong. Preliminary trial of ezetimibe combined with atorvastatin in treatment of patient with nonalcoholic fatty liver disease complicated by coronary heart disease [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 405-408.
[15]	Zeng Minde. Mechanisms of lipotoxicity in pathogenesis of nonalcoholic fatty liver diseases [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(2): 153-156.

Improved compliance of life style in patients with nonalcoholic fatty liver disease by family visit based on cross-theretical model of change

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments